ClinicalTrials.gg
Drug

Dronabinol clinical trials

Also written Marinol, THC, ECP002A and SP-104.

studies test it
183
open now
42
in phase 3
19
first study started
2001

How each study uses Dronabinol is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Dronabinol studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
31 May 1985 · MARINOL · NDA 018651 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Dronabinol
68
Cannabis
10
Delta-9-THC
9
marijuana
6
Active Delta-9-THC
4

Brand

Marinol
42

Development codes

ECP002A
3
SP-104
2
AP707
1
THC 20mg
1
AVCN319301b
1
THC 30mg
1
THC 10
1

Other names

THC
41
delta-9-tetrahydrocannabinol
15
Tetrahydrocannabinol
14
Namisol
7

In one entry with another drug

Given together, or one or the other

THC/CBD
2

Studies by the year they started

180 studies that test it; most in 2025 (21); 2 more planned to start later

Studies that test Dronabinol, by start year
YearStudies
20012
20021
20032
20041
20053
20067
20075
20085
20096
20104
20117
20128
20134
20149
20158
20161
201711
201812
20197
20207
202110
20229
20239
20245
202521
202616

By phase

A phase 1/2 study counts in both.

Early Phase 1
24
Phase 1
58
Phase 2
65
Phase 3
19
Phase 4
12
No phase
23

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 18 · Other 165

Yale University (24) · Johns Hopkins University (13) · University of Chicago (8) · Radboud University Medical Center (7) · University of California, San Diego (6) · Wayne State University (4) · New York State Psychiatric Institute (4) · National Institute on Drug Abuse (NIDA) (4)

Often tested with

Tested in the same studies.

Cannabidiol (30) · Cannabis sativa subsp. indica TOP (4) · Nabiximols (3) · Delta-8-tetrahydrocannabinol (2) · Ethanol (1) · Alpha-pinene (1) · Caffeine (1) · Naloxone (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 18, 1 in phase 3

Studies that test Dronabinol, phase 3 first.

Studies

Open first, then newest update. How each study uses Dronabinol is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 183

See all 183 studies that test Dronabinol →

Given beside what is tested · 6 — Dronabinol is usual care or a partner of the new treatment
As the comparator · 7 — what is tested is compared with Dronabinol

Codes

What other systems call Dronabinol · ClinicalTrials.gg INT008296

  • MeSH (NLM) D013759DronabinolConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 7J8897W37SDRONABINOLConfirmed FDA, NLM
  • RxNorm 10402One source FDA
  • NCI Thesaurus C867DronabinolOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.